MSA Safety Incorporated MSA
Composite 61/100; the shares have moved about 28% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Income ranks 47/100 — a slight mark against it.
Balance-sheet strength ranks 80/100 — a strong point in its favour. Quality ranks 68/100 — a moderate point in its favour. Momentum ranks 59/100 — a slight point in its favour.
Income ranks 47/100 — a slight mark against it. Growth ranks 48/100 — a slight mark against it. Valuation ranks 49/100 — a slight mark against it.
What the company does MSA Safety designs, manufactures, and markets safety equipment and technology for worker and infrastructure protection across fire service, energy, construction, and industrial sectors. Its portfolio spans breathing apparatus, gas detection systems, helmets, fall protection, and eye/face protection, sold globally via distributors and direct channels.
Key financials MSA posts strong profitability with ROE 22.8%, ROA 11.3%, and ROCE 18.3%. Margins are healthy: gross 46.8%, operating 22.4%, net 15.2%. Revenue grew 10.0% and EPS 21.2%, supported by a solid balance sheet (debt/equity 0.43, interest coverage 12.79) and liquidity (current ratio 3.24).
Stock health Momentum is robust: +17.07% over 3m, +9.56% over 6m, with RSI(14) at 74.60 indicating overbought conditions. The stock is -6.52% below its 52-week high. Sidera’s overall score is 63.8, with strength at 81.9 and valuation at 52.1.
Price vs fair value MSA trades at a PREMIUM of 47.20% to our fair-value estimate of 102.53 and a discount of 5.94% to the analyst 12-month target of 205.71. - Q2 2026 results beat earnings and revenue estimates (Zacks). - Q2 sales exceeded expectations (StockStory). - Analysts highlight better-than-expected performance as a driver of the premium (Zacks, StockStory).
Looking forward Forward P/E of 19.61 and PEG of 0.96 suggest reasonable earnings growth expectations. Analysts see 12-month upside to 205.71, while our fair-value estimate implies further valuation compression unless growth accelerates.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.